Chun‐Ming Tsai

11.8k total citations · 4 hit papers
114 papers, 7.8k citations indexed

About

Chun‐Ming Tsai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Chun‐Ming Tsai has authored 114 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Pulmonary and Respiratory Medicine, 84 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Chun‐Ming Tsai's work include Lung Cancer Treatments and Mutations (89 papers), Lung Cancer Research Studies (48 papers) and Lung Cancer Diagnosis and Treatment (37 papers). Chun‐Ming Tsai is often cited by papers focused on Lung Cancer Treatments and Mutations (89 papers), Lung Cancer Research Studies (48 papers) and Lung Cancer Diagnosis and Treatment (37 papers). Chun‐Ming Tsai collaborates with scholars based in Taiwan, United States and South Korea. Chun‐Ming Tsai's co-authors include James Chih‐Hsin Yang, Vera Hirsh, Tony Mok, Sumitra Thongprasert, Lecia V. Sequist, Wu‐Chou Su, Joseph S. K. Au, Sarayut Lucien Geater, Michael Boyer and Martin Schüler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chun‐Ming Tsai

111 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

2013 2.5k citations Lecia V. Sequist, James Chih‐Hsin Yang et al. Journal of Clinical Oncology profile →
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

2014 1.1k citations Chun‐Ming Tsai, Pan‐Chyr Yang et al. Journal of Thoracic Oncology profile →
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

2016 502 citations Chun‐Ming Tsai, Gee‐Chen Chang et al. profile →
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

2013 383 citations Vera Hirsh, Chun‐Ming Tsai et al. profile →

Peers

Countries citing papers authored by Chun‐Ming Tsai

Since Specialization

Citations

This map shows the geographic impact of Chun‐Ming Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Ming Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Ming Tsai more than expected).

Fields of papers citing papers by Chun‐Ming Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Ming Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Ming Tsai. The network helps show where Chun‐Ming Tsai may publish in the future.

Co-authorship network of co-authors of Chun‐Ming Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Ming Tsai. A scholar is included among the top collaborators of Chun‐Ming Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Ming Tsai. Chun‐Ming Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	418P Concordance of PI3K-AKT pathway alterations between tumor and ctDNA in metastatic breast cancer	Annals of Oncology	Chun‐Ming Tsai, Luc Cabel et al.	0
2	Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer	PLoS ONE	Hsiang‐Ling Ho, Yuqiu Jiang et al.	8
3	Dynamic Assessment of Tissue and Plasma EGFR-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs	International Journal of Molecular Sciences	Hsiang‐Ling Ho, Fangyu Wang et al.	9
4	Sequence for Surgical Resection of Primary Lung Tumor for Oligometastatic Non-small Cell Lung Cancer	The Annals of Thoracic Surgery	Chien‐Sheng Huang, Hui‐Shan Chen et al.	3
5	PL03.07: First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)	Journal of Thoracic Oncology	Gilberto de Castro, Daniel Shao-Weng Tan et al.	8
6	P3.02a-025 PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4)	Journal of Thoracic Oncology	Daniel Shao-Weng Tan, Jean‐Charles Soria et al.	2
7	P1.33: Afatinib Versus Chemotherapy for EGFR Mutation-Positive NSCLC Patients Aged ≥65 Years: Subgroup Analysis of LUX-Lung 3/6	Journal of Thoracic Oncology	Luis Fein, Yi‐Long Wu et al.	4
8	Concomitant Primary Lung Cancer and Metastatic Pulmonary Colorectal Cancer that Responded to Gemcitabine/Cisplatin/Bevacizumab Combination Therapy	SHILAP Revista de lepidopterología	Hung-Ming Chen, Chin‐Chen Pan et al.	4
9	First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial	Clinical Lung Cancer	Mark E. Boye, Xin Wang et al.	13
10	Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations breakdown →	Journal of Clinical Oncology	Lecia V. Sequist, James Chih‐Hsin Yang et al.	2461
11	Histological Subtypes of Lung Adenocarcinoma Have Differential 18F-Fluorodeoxyglucose Uptakes on the Positron Emission Tomography/Computed Tomography Scan	Journal of Thoracic Oncology	Chao‐Hua Chiu, Yi‐Chen Yeh et al.	41
12	Second-Line Therapy for Elderly Patients with Non-small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients	Journal of Thoracic Oncology	Yuh‐Min Chen, Kun‐Ta Chou et al.	16
13	Revisiting Squamous Cell Carcinoma of the Lungs-A Disease Given Less Attention		Yuh‐Min Chen, Jen-Fu Shih et al.	1
14	Predictive Factors of Gefitinib Antitumor Activity in East Asian Advanced Non-small Cell Lung Cancer Patients	Journal of Thoracic Oncology	Gee‐Chen Chang, Chun‐Ming Tsai et al.	32
15	Phase II Randomized Trial of Tri-weekly Versus Days 1 and 8 Weekly Docetaxel as a Second-line Treatment of Advanced Non-small Cell Lung Cancer	Japanese Journal of Clinical Oncology	Chun‐Liang Lai, Chun‐Ming Tsai et al.	31
16	Interleukin-7 and Interleukin-12 Have Different Effects in Rescue of Depressed Cellular Immunity: Comparison of Malignant and Tuberculous Pleural Effusions	Journal of Interferon & Cytokine Research	Yuh‐Min Chen, Chun‐Ming Tsai et al.	6
17	Interrelationships between Cellular Nucleotide Excision Repair, Cisplatin Cytotoxicity, HER‐2/neu Gene Expression, and Epidermal Growth Factor Receptor Level in Non‐small Cell Lung Cancer Cells	Japanese Journal of Cancer Research	Chun‐Ming Tsai, Li Lan et al.	26
18	Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.	PubMed	Chun‐Ming Tsai, A Levitzki et al.	74
19	Elevation of Serum Interleukin-6 Levels Before Peak of Serum Granulocyte Colony-Stimulating Factor Level in Chemotherapy-Induced Myelosuppressive Patients	Journal of Immunotherapy	Yuh-Min Chen, Jacqueline Whang‐Peng et al.	3
20	Enhancement of fluorinated pyrimidine‐induced cytotoxicity by leucovorin in human lung cancer cell lines	International Journal of Cancer	Chun‐Ming Tsai, Adi F. Gazdar et al.	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact